The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis

Jacek Staszewski,1 Aleksandra Pogoda,1 Kamila Data,1 Klaudia Walczak,1 Maciej Nowocień,2 Emilia Frankowska,2 Adam Stępień1 1Clinic of Neurology, Military Institute of Medicine, Warsaw, Poland; 2Department of Radiology, Military Institute of Medicine, Warsaw, Poland Purpose: The role of biomarkers...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Staszewski J, Pogoda A, Data K, Walczak K, Nowocień M, Frankowska E, Stępień A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
MPV
Acceso en línea:https://doaj.org/article/04b7df52796f4474919b79891ac4ce84
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:04b7df52796f4474919b79891ac4ce84
record_format dspace
spelling oai:doaj.org-article:04b7df52796f4474919b79891ac4ce842021-12-02T00:49:08ZThe mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis1178-1998https://doaj.org/article/04b7df52796f4474919b79891ac4ce842019-02-01T00:00:00Zhttps://www.dovepress.com/the-mean-platelet-volume-on-admission-predicts-unfavorable-stroke-outc-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Jacek Staszewski,1 Aleksandra Pogoda,1 Kamila Data,1 Klaudia Walczak,1 Maciej Nowocień,2 Emilia Frankowska,2 Adam Stępień1 1Clinic of Neurology, Military Institute of Medicine, Warsaw, Poland; 2Department of Radiology, Military Institute of Medicine, Warsaw, Poland Purpose: The role of biomarkers in the prediction of acute ischemic stroke (AIS) outcome or response to thrombolytic therapy (with recombinant tissue plasminogen activator [rt-PA]) remains limited. The aim of this study was to evaluate whether mean platelet volume (MPV) could predict short-term functional outcome in patients with AIS following rt-PA treatment.Patients and methods: This was a retrospective analysis of 237 AIS patients (mean age 71.04±0.8 years, 50.6% women) consecutively admitted to a tertiary care center between 2011 and 2015.Results: The mean MPV in the cohort was 9.8±0.35 fL (lowest tertile 8.8 fL). Patients in the lowest tertile compared to median and highest tertiles were less often dependent (modified Rankin scale [mRS] ≥3) at admission (87.2% vs 96.1% and 96.1%, respectively, P=0.04) and less often had a poor stroke outcome (mRS 4–6) at discharge (28.2% vs 55.3% and 44.7%, P<0.01). However, there was no significant difference between tertiles with regard to AIS etiology, CT (Alberta Stroke Program Early CT) score, frequency of stroke due to large artery occlusion, risk of secondary hemorrhage, and early neurologic deterioration. Multivariable analysis after adjustment for confounders showed that patients in the second and third tertiles had a significantly higher risk of poor stroke outcome (OR =1.9, 95% CI =1.01–4), lack of early improvement (OR =1.91, 95% CI =1.05–3.47), lower chance of good outcome (mRS 0–2; OR =0.38, 95% CI =0.18–0.78), or minor stroke at discharge (OR =0.47, 95% CI =0.26–0.84). Receiver operating characteristic analysis for prediction of poor stroke outcome showed that the optimal cut-off point of MPV was 8.8 fL (area under the curve 0.586 [0.512–0.659], P=0.03) with a sensitivity of 82.7% and a specificity of 43.9%.Conclusion: Disabling or fatal ischemic stroke in thrombolyzed patients was observed more often in patients with high admission MPV. The prognostic value of MPV was independent of other well-defined individual risk factors. Keywords: acute ischemic stroke, rt-PA, prognosis, MPV, biomarker, platelet activity, reperfusion  Staszewski JPogoda AData KWalczak KNowocień MFrankowska EStępień ADove Medical Pressarticleacute ischemic strokert-PAprognosisMPVbiomarkerGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 14, Pp 493-503 (2019)
institution DOAJ
collection DOAJ
language EN
topic acute ischemic stroke
rt-PA
prognosis
MPV
biomarker
Geriatrics
RC952-954.6
spellingShingle acute ischemic stroke
rt-PA
prognosis
MPV
biomarker
Geriatrics
RC952-954.6
Staszewski J
Pogoda A
Data K
Walczak K
Nowocień M
Frankowska E
Stępień A
The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis
description Jacek Staszewski,1 Aleksandra Pogoda,1 Kamila Data,1 Klaudia Walczak,1 Maciej Nowocień,2 Emilia Frankowska,2 Adam Stępień1 1Clinic of Neurology, Military Institute of Medicine, Warsaw, Poland; 2Department of Radiology, Military Institute of Medicine, Warsaw, Poland Purpose: The role of biomarkers in the prediction of acute ischemic stroke (AIS) outcome or response to thrombolytic therapy (with recombinant tissue plasminogen activator [rt-PA]) remains limited. The aim of this study was to evaluate whether mean platelet volume (MPV) could predict short-term functional outcome in patients with AIS following rt-PA treatment.Patients and methods: This was a retrospective analysis of 237 AIS patients (mean age 71.04±0.8 years, 50.6% women) consecutively admitted to a tertiary care center between 2011 and 2015.Results: The mean MPV in the cohort was 9.8±0.35 fL (lowest tertile 8.8 fL). Patients in the lowest tertile compared to median and highest tertiles were less often dependent (modified Rankin scale [mRS] ≥3) at admission (87.2% vs 96.1% and 96.1%, respectively, P=0.04) and less often had a poor stroke outcome (mRS 4–6) at discharge (28.2% vs 55.3% and 44.7%, P<0.01). However, there was no significant difference between tertiles with regard to AIS etiology, CT (Alberta Stroke Program Early CT) score, frequency of stroke due to large artery occlusion, risk of secondary hemorrhage, and early neurologic deterioration. Multivariable analysis after adjustment for confounders showed that patients in the second and third tertiles had a significantly higher risk of poor stroke outcome (OR =1.9, 95% CI =1.01–4), lack of early improvement (OR =1.91, 95% CI =1.05–3.47), lower chance of good outcome (mRS 0–2; OR =0.38, 95% CI =0.18–0.78), or minor stroke at discharge (OR =0.47, 95% CI =0.26–0.84). Receiver operating characteristic analysis for prediction of poor stroke outcome showed that the optimal cut-off point of MPV was 8.8 fL (area under the curve 0.586 [0.512–0.659], P=0.03) with a sensitivity of 82.7% and a specificity of 43.9%.Conclusion: Disabling or fatal ischemic stroke in thrombolyzed patients was observed more often in patients with high admission MPV. The prognostic value of MPV was independent of other well-defined individual risk factors. Keywords: acute ischemic stroke, rt-PA, prognosis, MPV, biomarker, platelet activity, reperfusion  
format article
author Staszewski J
Pogoda A
Data K
Walczak K
Nowocień M
Frankowska E
Stępień A
author_facet Staszewski J
Pogoda A
Data K
Walczak K
Nowocień M
Frankowska E
Stępień A
author_sort Staszewski J
title The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis
title_short The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis
title_full The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis
title_fullStr The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis
title_full_unstemmed The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis
title_sort mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with iv thrombolysis
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/04b7df52796f4474919b79891ac4ce84
work_keys_str_mv AT staszewskij themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT pogodaa themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT datak themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT walczakk themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT nowocienm themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT frankowskae themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT stepiena themeanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT staszewskij meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT pogodaa meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT datak meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT walczakk meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT nowocienm meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT frankowskae meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
AT stepiena meanplateletvolumeonadmissionpredictsunfavorablestrokeoutcomesinpatientstreatedwithivthrombolysis
_version_ 1718403416331386880